Report Cover

Global OTC Anti-Infective Products Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026


The OTC Anti-Infective Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global OTC Anti-Infective Products size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global OTC Anti-Infective Products market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
OTC Anti-Infective Products market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Antifungals
    Antiseptic
    Antiparasitics

Market segment by Application can be divided into
    Hospital Pharmacies
    Drug Stores
    Retail Stores
    E-Commerce

The key market players for global OTC Anti-Infective Products market are listed below:
    GlaxoSmithKline
    Merck
    Pfizer
    Novartis
    Abbott
    Sanofi
    Bristol-Myers Squibb
    Roche
    NanoViricides
    Novabay Pharmaceuticals
    Optimer Pharmaceuticals
    Basilea Pharmaceutica
    MerLion Pharma

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
    1.1 OTC Anti-Infective Products Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global OTC Anti-Infective Products Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Antifungals
        1.2.3 Antiseptic
        1.2.4 Antiparasitics
    1.3 Market Analysis by Application
        1.3.1 Overview: Global OTC Anti-Infective Products Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Hospital Pharmacies
        1.3.3 Drug Stores
        1.3.4 Retail Stores
        1.3.5 E-Commerce
    1.4 Global OTC Anti-Infective Products Market Size & Forecast
        1.4.1 Global OTC Anti-Infective Products Sales in Value (2016-2026))
        1.4.2 Global OTC Anti-Infective Products Sales in Volume (2016-2026)
        1.4.3 Global OTC Anti-Infective Products Price by Type (2016-2026) & (USD/Unit)
    1.5 Global OTC Anti-Infective Products Production Capacity Analysis
        1.5.1 Global OTC Anti-Infective Products Total Production Capacity (2016-2026)
        1.5.2 Global OTC Anti-Infective Products Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 OTC Anti-Infective Products Market Drivers
        1.6.2 OTC Anti-Infective Products Market Restraints
        1.6.3 OTC Anti-Infective Products Trends Analysis
2 Manufacturers Profiles
    2.1 GlaxoSmithKline
        2.1.1 GlaxoSmithKline Details
        2.1.2 GlaxoSmithKline Major Business
        2.1.3 GlaxoSmithKline OTC Anti-Infective Products Product and Services
        2.1.4 GlaxoSmithKline OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.2 Merck
        2.2.1 Merck Details
        2.2.2 Merck Major Business
        2.2.3 Merck OTC Anti-Infective Products Product and Services
        2.2.4 Merck OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.3 Pfizer
        2.3.1 Pfizer Details
        2.3.2 Pfizer Major Business
        2.3.3 Pfizer OTC Anti-Infective Products Product and Services
        2.3.4 Pfizer OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.4 Novartis
        2.4.1 Novartis Details
        2.4.2 Novartis Major Business
        2.4.3 Novartis OTC Anti-Infective Products Product and Services
        2.4.4 Novartis OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.5 Abbott
        2.5.1 Abbott Details
        2.5.2 Abbott Major Business
        2.5.3 Abbott OTC Anti-Infective Products Product and Services
        2.5.4 Abbott OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.6 Sanofi
        2.6.1 Sanofi Details
        2.6.2 Sanofi Major Business
        2.6.3 Sanofi OTC Anti-Infective Products Product and Services
        2.6.4 Sanofi OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.7 Bristol-Myers Squibb
        2.7.1 Bristol-Myers Squibb Details
        2.7.2 Bristol-Myers Squibb Major Business
        2.7.3 Bristol-Myers Squibb OTC Anti-Infective Products Product and Services
        2.7.4 Bristol-Myers Squibb OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.8 Roche
        2.8.1 Roche Details
        2.8.2 Roche Major Business
        2.8.3 Roche OTC Anti-Infective Products Product and Services
        2.8.4 Roche OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.9 NanoViricides
        2.9.1 NanoViricides Details
        2.9.2 NanoViricides Major Business
        2.9.3 NanoViricides OTC Anti-Infective Products Product and Services
        2.9.4 NanoViricides OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.10 Novabay Pharmaceuticals
        2.10.1 Novabay Pharmaceuticals Details
        2.10.2 Novabay Pharmaceuticals Major Business
        2.10.3 Novabay Pharmaceuticals OTC Anti-Infective Products Product and Services
        2.10.4 Novabay Pharmaceuticals OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.11 Optimer Pharmaceuticals
        2.11.1 Optimer Pharmaceuticals Details
        2.11.2 Optimer Pharmaceuticals Major Business
        2.11.3 Optimer Pharmaceuticals OTC Anti-Infective Products Product and Services
        2.11.4 Optimer Pharmaceuticals OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.12 Basilea Pharmaceutica
        2.12.1 Basilea Pharmaceutica Details
        2.12.2 Basilea Pharmaceutica Major Business
        2.12.3 Basilea Pharmaceutica OTC Anti-Infective Products Product and Services
        2.12.4 Basilea Pharmaceutica OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.13 MerLion Pharma
        2.13.1 MerLion Pharma Details
        2.13.2 MerLion Pharma Major Business
        2.13.3 MerLion Pharma OTC Anti-Infective Products Product and Services
        2.13.4 MerLion Pharma OTC Anti-Infective Products Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 OTC Anti-Infective Products Sales by Manufacturer
    3.1 Global OTC Anti-Infective Products Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global OTC Anti-Infective Products Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in OTC Anti-Infective Products
    3.4 Market Concentration Rate
        3.4.1 Top 3 OTC Anti-Infective Products Manufacturer Market Share
        3.4.2 Top 6 OTC Anti-Infective Products Manufacturer Market Share
    3.5 Global OTC Anti-Infective Products Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and OTC Anti-Infective Products Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global OTC Anti-Infective Products Market Size by Region
        4.1.1 Global OTC Anti-Infective Products Sales in Volume by Region (2016-2026)
        4.1.2 Global OTC Anti-Infective Products Revenue by Region (2016-2026)
    4.2 North America OTC Anti-Infective Products Revenue (2016-2026)
    4.3 Europe OTC Anti-Infective Products Revenue (2016-2026)
    4.4 Asia-Pacific OTC Anti-Infective Products Revenue (2016-2026)
    4.5 South America OTC Anti-Infective Products Revenue (2016-2026)
    4.6 Middle East and Africa OTC Anti-Infective Products Revenue (2016-2026)
5 Market Segment by Type
    5.1 Global OTC Anti-Infective Products Sales in Volume by Type (2016-2026)
    5.2 Global OTC Anti-Infective Products Revenue by Type (2016-2026)
    5.3 Global OTC Anti-Infective Products Price by Type (2016-2026)
6 Market Segment by Application
    6.1 Global OTC Anti-Infective Products Sales in Volume by Application (2016-2026)
    6.2 Global OTC Anti-Infective Products Revenue by Application (2016-2026)
    6.3 Global OTC Anti-Infective Products Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
    7.1 North America OTC Anti-Infective Products Sales by Type (2016-2026)
    7.2 North America OTC Anti-Infective Products Sales by Application (2016-2026)
    7.3 North America OTC Anti-Infective Products Market Size by Country
        7.3.1 North America OTC Anti-Infective Products Sales in Volume by Country (2016-2026)
        7.3.2 North America OTC Anti-Infective Products Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
    8.1 Europe OTC Anti-Infective Products Sales by Type (2016-2026)
    8.2 Europe OTC Anti-Infective Products Sales by Application (2016-2026)
    8.3 Europe OTC Anti-Infective Products Market Size by Country
        8.3.1 Europe OTC Anti-Infective Products Sales in Volume by Country (2016-2026)
        8.3.2 Europe OTC Anti-Infective Products Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific OTC Anti-Infective Products Sales by Type (2016-2026)
    9.2 Asia-Pacific OTC Anti-Infective Products Sales by Application (2016-2026)
    9.3 Asia-Pacific OTC Anti-Infective Products Market Size by Region
        9.3.1 Asia-Pacific OTC Anti-Infective Products Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific OTC Anti-Infective Products Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
    10.1 South America OTC Anti-Infective Products Sales by Type (2016-2026)
    10.2 South America OTC Anti-Infective Products Sales by Application (2016-2026)
    10.3 South America OTC Anti-Infective Products Market Size by Country
        10.3.1 South America OTC Anti-Infective Products Sales in Volume by Country (2016-2026)
        10.3.2 South America OTC Anti-Infective Products Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa OTC Anti-Infective Products Sales by Type (2016-2026)
    11.2 Middle East & Africa OTC Anti-Infective Products Sales by Application (2016-2026)
    11.3 Middle East & Africa OTC Anti-Infective Products Market Size by Country
        11.3.1 Middle East & Africa OTC Anti-Infective Products Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa OTC Anti-Infective Products Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 OTC Anti-Infective Products Typical Distributors
    12.3 OTC Anti-Infective Products Typical Customers
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

List of Tables Table 1. Global OTC Anti-Infective Products Revenue by Type, (USD Million), 2021-2026 Table 2. Global OTC Anti-Infective Products Revenue by Application, (USD Million), 2021-2026 Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors Table 4. GlaxoSmithKline Major Business Table 5. GlaxoSmithKline OTC Anti-Infective Products Product and Services Table 6. GlaxoSmithKline OTC Anti-Infective Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 7. Merck Basic Information, Manufacturing Base and Competitors Table 8. Merck Major Business Table 9. Merck OTC Anti-Infective Products Product and Services Table 10. Merck OTC Anti-Infective Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 11. Pfizer Basic Information, Manufacturing Base and Competitors Table 12. Pfizer Major Business Table 13. Pfizer OTC Anti-Infective Products Product and Services Table 14. Pfizer OTC Anti-Infective Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 15. Novartis Basic Information, Manufacturing Base and Competitors Table 16. Novartis Major Business Table 17. Novartis OTC Anti-Infective Products Product and Services Table 18. Novartis OTC Anti-Infective Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 19. Abbott Basic Information, Manufacturing Base and Competitors Table 20. Abbott Major Business Table 21. Abbott OTC Anti-Infective Products Product and Services Table 22. Abbott OTC Anti-Infective Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 23. Sanofi Basic Information, Manufacturing Base and Competitors Table 24. Sanofi Major Business Table 25. Sanofi OTC Anti-Infective Products Product and Services Table 26. Sanofi OTC Anti-Infective Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 27. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors Table 28. Bristol-Myers Squibb Major Business Table 29. Bristol-Myers Squibb OTC Anti-Infective Products Product and Services Table 30. Bristol-Myers Squibb OTC Anti-Infective Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 31. Roche Basic Information, Manufacturing Base and Competitors Table 32. Roche Major Business Table 33. Roche OTC Anti-Infective Products Product and Services Table 34. Roche OTC Anti-Infective Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 35. NanoViricides Basic Information, Manufacturing Base and Competitors Table 36. NanoViricides Major Business Table 37. NanoViricides OTC Anti-Infective Products Product and Services Table 38. NanoViricides OTC Anti-Infective Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 39. Novabay Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table 40. Novabay Pharmaceuticals Major Business Table 41. Novabay Pharmaceuticals OTC Anti-Infective Products Product and Services Table 42. Novabay Pharmaceuticals OTC Anti-Infective Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 43. Optimer Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table 44. Optimer Pharmaceuticals Major Business Table 45. Optimer Pharmaceuticals OTC Anti-Infective Products Product and Services Table 46. Optimer Pharmaceuticals OTC Anti-Infective Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 47. Basilea Pharmaceutica Basic Information, Manufacturing Base and Competitors Table 48. Basilea Pharmaceutica Major Business Table 49. Basilea Pharmaceutica OTC Anti-Infective Products Product and Services Table 50. Basilea Pharmaceutica OTC Anti-Infective Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 51. MerLion Pharma Basic Information, Manufacturing Base and Competitors Table 52. MerLion Pharma Major Business Table 53. MerLion Pharma OTC Anti-Infective Products Product and Services Table 54. MerLion Pharma OTC Anti-Infective Products Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 55. Global OTC Anti-Infective Products Sales by Manufacturer (2019-2021e) & (K Units) Table 56. Global OTC Anti-Infective Products Revenue by Manufacturer (2019-2021e) & (USD Million) Table 57. Market Position of Manufacturers in OTC Anti-Infective Products, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020 Table 58. Global OTC Anti-Infective Products Production Capacity by Company, (K Units): 2020 VS 2021 Table 59. Head Office and OTC Anti-Infective Products Production Site of Key Manufacturer Table 60. Global OTC Anti-Infective Products Sales by Region (2016-2021e) & (K Units) Table 61. Global OTC Anti-Infective Products Sales by Region (2021-2026) & (K Units) Table 62. Global OTC Anti-Infective Products Revenue by Region (2016-2021e) & (USD Million) Table 63. Global OTC Anti-Infective Products Revenue by Region (2021-2026) & (USD Million) Table 64. Global OTC Anti-Infective Products Sales by Type (2016-2021e) & (K Units) Table 65. Global OTC Anti-Infective Products Sales by Type (2021-2026) & (K Units) Table 66. Global OTC Anti-Infective Products Revenue by Type (2016-2021e) & (USD Million) Table 67. Global OTC Anti-Infective Products Revenue by Type (2021-2026) & (USD Million) Table 68. Global OTC Anti-Infective Products Price by Type (2016-2021e) & (USD/Unit) Table 69. Global OTC Anti-Infective Products Price by Type (2021-2026) & (USD/Unit) Table 70. Global OTC Anti-Infective Products Sales by Application (2016-2021e) & (K Units) Table 71. Global OTC Anti-Infective Products Sales by Application (2021-2026) & (K Units) Table 72. Global OTC Anti-Infective Products Revenue by Application (2016-2021e) & (USD Million) Table 73. Global OTC Anti-Infective Products Revenue by Application (2021-2026) & (USD Million) Table 74. Global OTC Anti-Infective Products Price by Application (2016-2021e) & (USD/Unit) Table 75. Global OTC Anti-Infective Products Price by Application (2021-2026) & (USD/Unit) Table 76. North America OTC Anti-Infective Products Sales by Country (2016-2021e) & (K Units) Table 77. North America OTC Anti-Infective Products Sales by Country (2021-2026) & (K Units) Table 78. North America OTC Anti-Infective Products Revenue by Country (2016-2021e) & (USD Million) Table 79. North America OTC Anti-Infective Products Revenue by Country (2021-2026) & (USD Million) Table 80. North America OTC Anti-Infective Products Sales by Type (2016-2021e) & (K Units) Table 81. North America OTC Anti-Infective Products Sales by Type (2021-2026) & (K Units) Table 82. North America OTC Anti-Infective Products Sales by Application (2016-2021e) & (K Units) Table 83. North America OTC Anti-Infective Products Sales by Application (2021-2026) & (K Units) Table 84. Europe OTC Anti-Infective Products Sales by Country (2016-2021e) & (K Units) Table 85. Europe OTC Anti-Infective Products Sales by Country (2021-2026) & (K Units) Table 86. Europe OTC Anti-Infective Products Revenue by Country (2016-2021e) & (USD Million) Table 87. Europe OTC Anti-Infective Products Revenue by Country (2021-2026) & (USD Million) Table 88. Europe OTC Anti-Infective Products Sales by Type (2016-2021e) & (K Units) Table 89. Europe OTC Anti-Infective Products Sales by Type (2021-2026) & (K Units) Table 90. Europe OTC Anti-Infective Products Sales by Application (2016-2021e) & (K Units) Table 91. Europe OTC Anti-Infective Products Sales by Application (2021-2026) & (K Units) Table 92. Asia-Pacific OTC Anti-Infective Products Sales by Region (2016-2021e) & (K Units) Table 93. Asia-Pacific OTC Anti-Infective Products Sales by Region (2021-2026) & (K Units) Table 94. Asia-Pacific OTC Anti-Infective Products Revenue by Region (2016-2021e) & (USD Million) Table 95. Asia-Pacific OTC Anti-Infective Products Revenue by Region (2021-2026) & (USD Million) Table 96. Asia-Pacific OTC Anti-Infective Products Sales by Type (2016-2021e) & (K Units) Table 97. Asia-Pacific OTC Anti-Infective Products Sales by Type (2021-2026) & (K Units) Table 98. Asia-Pacific OTC Anti-Infective Products Sales by Application (2016-2021e) & (K Units) Table 99. Asia-Pacific OTC Anti-Infective Products Sales by Application (2021-2026) & (K Units) Table 100. South America OTC Anti-Infective Products Sales by Country (2016-2021e) & (K Units) Table 101. South America OTC Anti-Infective Products Sales by Country (2021-2026) & (K Units) Table 102. South America OTC Anti-Infective Products Revenue by Country (2016-2021e) & (USD Million) Table 103. South America OTC Anti-Infective Products Revenue by Country (2021-2026) & (USD Million) Table 104. South America OTC Anti-Infective Products Sales by Type (2016-2021e) & (K Units) Table 105. South America OTC Anti-Infective Products Sales by Type (2021-2026) & (K Units) Table 106. South America OTC Anti-Infective Products Sales by Application (2016-2021e) & (K Units) Table 107. South America OTC Anti-Infective Products Sales by Application (2021-2026) & (K Units) Table 108. Middle East & Africa OTC Anti-Infective Products Sales by Country (2016-2021e) & (K Units) Table 109. Middle East & Africa OTC Anti-Infective Products Sales by Country (2021-2026) & (K Units) Table 110. Middle East & Africa OTC Anti-Infective Products Revenue by Country (2016-2021e) & (USD Million) Table 111. Middle East & Africa OTC Anti-Infective Products Revenue by Country (2021-2026) & (USD Million) Table 112. Middle East & Africa OTC Anti-Infective Products Sales by Type (2016-2021e) & (K Units) Table 113. Middle East & Africa OTC Anti-Infective Products Sales by Type (2021-2026) & (K Units) Table 114. Middle East & Africa OTC Anti-Infective Products Sales by Application (2016-2021e) & (K Units) Table 115. Middle East & Africa OTC Anti-Infective Products Sales by Application (2021-2026) & (K Units) Table 116. Direct Channel Pros & Cons Table 117. Indirect Channel Pros & Cons Table 118. OTC Anti-Infective Products Typical Distributors Table 119. OTC Anti-Infective Products Typical Customers List of Figures Figure 1. OTC Anti-Infective Products Picture Figure 2. Global OTC Anti-Infective Products Sales Market Share by Type in 2020 Figure 3. Antifungals Figure 4. Antiseptic Figure 5. Antiparasitics Figure 6. Global OTC Anti-Infective Products Sales Market Share by Application in 2020 Figure 7. Hospital Pharmacies Figure 8. Drug Stores Figure 9. Retail Stores Figure 10. E-Commerce Figure 11. Global OTC Anti-Infective Products Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026 Figure 12. Global OTC Anti-Infective Products Market Size and Forecast (2016-2026) & (USD Million) Figure 13. United States OTC Anti-Infective Products Revenue and Growth Rate (2016-2026) & (USD Million) Figure 14. Canada OTC Anti-Infective Products Revenue and Growth Rate (2016-2026) & (USD Million) Figure 15. Mexico OTC Anti-Infective Products Revenue and Growth Rate (2016-2026) & (USD Million) Figure 16. Germany OTC Anti-Infective Products Revenue and Growth Rate (2016-2026) & (USD Million) Figure 17. France OTC Anti-Infective Products Revenue and Growth Rate (2016-2026) & (USD Million) Figure 18. United Kingdom OTC Anti-Infective Products Revenue and Growth Rate (2016-2026) & (USD Million) Figure 19. Russia OTC Anti-Infective Products Revenue and Growth Rate (2016-2026) & (USD Million) Figure 20. Italy OTC Anti-Infective Products Revenue and Growth Rate (2016-2026) & (USD Million) Figure 21. China OTC Anti-Infective Products Revenue and Growth Rate (2016-2026) & (USD Million) Figure 22. Japan OTC Anti-Infective Products Revenue and Growth Rate (2016-2026) & (USD Million) Figure 23. Korea OTC Anti-Infective Products Revenue and Growth Rate (2016-2026) & (USD Million) Figure 24. India OTC Anti-Infective Products Revenue and Growth Rate (2016-2026) & (USD Million) Figure 25. Southeast Asia OTC Anti-Infective Products Revenue and Growth Rate (2016-2026) & (USD Million) Figure 26. Australia OTC Anti-Infective Products Revenue and Growth Rate (2016-2026) & (USD Million) Figure 27. Brazil OTC Anti-Infective Products Revenue and Growth Rate (2016-2026) & (USD Million) Figure 28. Egypt OTC Anti-Infective Products Revenue and Growth Rate (2016-2026) & (USD Million) Figure 29. Saudi Arabia OTC Anti-Infective Products Revenue and Growth Rate (2016-2026) & (USD Million) Figure 30. South Africa OTC Anti-Infective Products Revenue and Growth Rate (2016-2026) & (USD Million) Figure 31. Turkey OTC Anti-Infective Products Revenue and Growth Rate (2016-2026) & (USD Million) Figure 32. Global OTC Anti-Infective Products Sales (2016-2026) & (K Units) Figure 33. Global OTC Anti-Infective Products Production Capacity (2016-2026) & (K Units) Figure 34. Global OTC Anti-Infective Products Production Capacity by Geographic Region: 2020 VS 2021 Figure 35. OTC Anti-Infective Products Market Drivers Figure 36. OTC Anti-Infective Products Market Restraints Figure 37. OTC Anti-Infective Products Market Trends Figure 38. Global OTC Anti-Infective Products Sales Market Share by Manufacturer in 2020 Figure 39. Global OTC Anti-Infective Products Revenue Market Share by Manufacturer in 2020 Figure 40. OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3) Figure 41. Top 3 OTC Anti-Infective Products Manufacturer (Revenue) Market Share in 2020 Figure 42. Top 6 OTC Anti-Infective Products Manufacturer (Revenue) Market Share in 2020 Figure 43. Global OTC Anti-Infective Products Sales Market Share by Region (2016-2026) Figure 44. Global OTC Anti-Infective Products Revenue Market Share by Region (2016-2026) Figure 45. North America OTC Anti-Infective Products Revenue (2016-2026) & (USD Million) Figure 46. Europe OTC Anti-Infective Products Revenue (2016-2026) & (USD Million) Figure 47. Asia-Pacific OTC Anti-Infective Products Revenue (2016-2026) & (USD Million) Figure 48. South America OTC Anti-Infective Products Revenue (2016-2026) & (USD Million) Figure 49. Middle East & Africa OTC Anti-Infective Products Revenue (2016-2026) & (USD Million) Figure 50. Global OTC Anti-Infective Products Sales Market Share by Type (2016-2026) Figure 51. Global OTC Anti-Infective Products Revenue Market Share by Type (2016-2026) Figure 52. Global OTC Anti-Infective Products Price by Type (2016-2026) & (USD/Unit) Figure 53. Global OTC Anti-Infective Products Sales Market Share by Application (2016-2026) Figure 54. Global OTC Anti-Infective Products Revenue Market Share by Application (2016-2026) Figure 55. Global OTC Anti-Infective Products Price by Application (2016-2026) & (USD/Unit) Figure 56. North America OTC Anti-Infective Products Sales Market Share by Country (2016-2026) Figure 57. North America OTC Anti-Infective Products Revenue Market Share by Country (2016-2026) Figure 58. North America OTC Anti-Infective Products Sales Market Share by Type (2016-2026) Figure 59. North America OTC Anti-Infective Products Sales Market Share by Application (2016-2026) Figure 60. Europe OTC Anti-Infective Products Sales Market Share by Country (2016-2026) Figure 61. Europe OTC Anti-Infective Products Revenue Market Share by Country (2016-2026) Figure 62. Europe OTC Anti-Infective Products Sales Market Share by Type (2016-2026) Figure 63. Europe OTC Anti-Infective Products Sales Market Share by Application (2016-2026) Figure 64. Asia-Pacific OTC Anti-Infective Products Sales Market Share by Region (2016-2026) Figure 65. Asia-Pacific OTC Anti-Infective Products Revenue Market Share by Region (2016-2026) Figure 66. Asia-Pacific OTC Anti-Infective Products Sales Market Share by Region (2016-2026) Figure 67. Asia-Pacific OTC Anti-Infective Products Sales Market Share by Application (2016-2026) Figure 68. South America OTC Anti-Infective Products Sales Market Share by Country (2016-2026) Figure 69. South America OTC Anti-Infective Products Revenue Market Share by Country (2016-2026) Figure 70. South America OTC Anti-Infective Products Sales Market Share by Type (2016-2026) Figure 71. South America OTC Anti-Infective Products Sales Market Share by Application (2016-2026) Figure 72. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Country (2016-2026) Figure 73. Middle East & Africa OTC Anti-Infective Products Revenue Market Share by Country (2016-2026) Figure 74. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Type (2016-2026) Figure 75. Middle East & Africa OTC Anti-Infective Products Sales Market Share by Application (2016-2026) Figure 76. Sales Channel: Direct Channel vs Indirect Channel Figure 77. Methodology Figure 78. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch
Chat with us